Literature DB >> 11789765

Heart-lung transplantation for Eisenmenger syndrome: early and long-term results.

S C Stoica1, K D McNeil, K Perreas, L D Sharples, D K Satchithananda, S S Tsui, S R Large, J Wallwork.   

Abstract

BACKGROUND: Heart-lung transplantation (HLT) for Eisenmenger syndrome (ES) provides superior early and intermediate survival when compared with other forms of transplantation. The early risk factors and long-term outcome of HLT for ES are less well defined.
METHODS: We analyzed 263 patients who had undergone HLT at our institution during more than 15 years. Fifty-one consecutive patients with ES who underwent HLT, 33 (65%) of which had simple anatomy, were compared with 212 cases having HLT for other indications (non-ES).
RESULTS: Female sex and previous thoracotomy were more prevalent in the ES group. Patients with ES had greater postoperative blood loss and returned more frequently to the operating room for control of bleeding. There were 8 (16%) early deaths in the ES group compared with 27 (13%) in non-ES (p = 0.65). One-, 5-, and 10-year survival rates for ES were 72.6%, 51.3%, and 27.6%, respectively, compared with non-ES of 74.1%, 48.1%, and 26.0%, respectively, and there was no difference in survival overall (p = 0.54). Among ES patients, previous thoracotomy was a risk factor for hospital death. A subgroup analysis based on simple versus complex type of ES did not show statistically significant differences in terms of postoperative course or early or late survival.
CONCLUSIONS: Heart-lung transplantation is a successful procedure for ES. Despite a greater frequency of risk factors and a more difficult operative course, early and late outcome with HLT is comparable to non-ES recipients.

Entities:  

Mesh:

Year:  2001        PMID: 11789765     DOI: 10.1016/s0003-4975(01)03099-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Heart-lung transplantation: current indications, prognosis and specific considerations.

Authors:  Jérôme Le Pavec; Sébastien Hascoët; Elie Fadel
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 2.  State of the Art of Combined Heart-Lung Transplantation for Advanced Cardiac and Pulmonary Dysfunction.

Authors:  Jay J Idrees; Gösta B Pettersson
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

3.  Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease.

Authors:  S C Apostolopoulou; A Manginas; D V Cokkinos; S Rammos
Journal:  Heart       Date:  2005-03-10       Impact factor: 5.994

4.  Anesthetic management of heart and lung transplantation: analysis of 14 cases in a single center.

Authors:  Jian Fang; Xiaoxue Zhuang; Zhaomin Huang; Lan Lan; Hanyu Yang; Chao Yang; Shaobo Xie
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 3.005

5.  First successful heart-lung transplantation in Japan: report of a case.

Authors:  Yoshiki Sawa; Goro Matsumiya; Shigefumi Shigemura; Hiroyuki Nishi; Hajime Ichikawa; Masato Minami; Norihide Fukushima; Masayoshi Inoue; Takayoshi Ueno; Akiyoshi Sawabatav; Taichi Sakaguchi; Shunsuke Saito; Meinoshin Okumura
Journal:  Surg Today       Date:  2013-02-20       Impact factor: 2.549

Review 6.  Should we perform bilateral-lung or heart–lung transplantation for patients with pulmonary hypertension?

Authors:  Anne Olland; Pierre-Emmanuel Falcoz; Mathieu Canuet; Gilbert Massard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

7.  The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects.

Authors:  Erwin Oechslin; Siegrun Mebus; Ingram Schulze-Neick; Koichiro Niwa; Pedro T Trindade; Andreas Eicken; Alfred Hager; Irene Lang; John Hess; Harald Kaemmerer
Journal:  Curr Cardiol Rev       Date:  2010-11

8.  Impact of advanced medical therapy for the outcome of an adult patient with Eisenmenger syndrome.

Authors:  Eglė Ereminienė; Marija Kinderytė; Skaidrius Miliauskas
Journal:  Respir Med Case Rep       Date:  2017-03-09

9.  Outcome after heart-lung or lung transplantation in patients with Eisenmenger syndrome.

Authors:  Cristel S Hjortshøj; Thomas Gilljam; Göran Dellgren; Markku O Pentikäinen; Thomas Möller; Annette Schophuus Jensen; Maila Turanlahti; Ulf Thilén; Finn Gustafsson; Lars Søndergaard
Journal:  Heart       Date:  2019-08-21       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.